Lumbard & Kellner’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Lumbard & Kellner's CDLX Position: Q2 2022 in Review
Lumbard & Kellner sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 655 shares — an estimated $359K sold.
Lumbard & Kellner first reported a position in CDLX in Q4 2020 and held it in 6 quarters. The position peaked at $1.22M in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.
- Lumbard & Kellner reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
- Lumbard & Kellner sold 655 Cardlytics shares in Q2 2022, an estimated $359K.
- Lumbard & Kellner first reported a position in Cardlytics in Q4 2020 and held it in 6 quarters.
- Lumbard & Kellner's Cardlytics position peaked at $1.22M in Q4 2020.
- 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.
Based on Lumbard & Kellner's 13F filing for Q2 2022, filed 15 Aug 2022.